NFE2L2 and breast carcinoma: Based on this study, NR5A2-NCOA3 exert their growth-stimulating role through the inhibition of ferroptosis induced by BETi, by increasing Nrf2 expression and inducing chemotherapy resistance in DA-MB-231 (MB-231), MDA-MB-468 (MB-468), and SK-BR breast cancer cell lines [135].